SEZGİN, G. Et Al. 2013. MEROPENEM VERSUS PIPERACILLIN-TAZOBACTAM AS EMPIRIC THERAPY FOR FEBRILE NEUTROPENIA IN PEDIATRIC ONCOLOGY PATIENTS. PEDIATRIC BLOOD & CANCER , vol.60 , 176-177.

SEZGİN, G., ACIPAYAM, C., ÖZKAN, A. K., KÜPELİ, S., BAYRAM, İ., & TANYELI, A., (2013). MEROPENEM VERSUS PIPERACILLIN-TAZOBACTAM AS EMPIRIC THERAPY FOR FEBRILE NEUTROPENIA IN PEDIATRIC ONCOLOGY PATIENTS. PEDIATRIC BLOOD & CANCER , vol.60, 176-177.

SEZGİN, GÜLAY Et Al. "MEROPENEM VERSUS PIPERACILLIN-TAZOBACTAM AS EMPIRIC THERAPY FOR FEBRILE NEUTROPENIA IN PEDIATRIC ONCOLOGY PATIENTS," PEDIATRIC BLOOD & CANCER , vol.60, 176-177, 2013

SEZGİN, GÜLAY Et Al. "MEROPENEM VERSUS PIPERACILLIN-TAZOBACTAM AS EMPIRIC THERAPY FOR FEBRILE NEUTROPENIA IN PEDIATRIC ONCOLOGY PATIENTS." PEDIATRIC BLOOD & CANCER , vol.60, pp.176-177, 2013

SEZGİN, G. Et Al. (2013) . "MEROPENEM VERSUS PIPERACILLIN-TAZOBACTAM AS EMPIRIC THERAPY FOR FEBRILE NEUTROPENIA IN PEDIATRIC ONCOLOGY PATIENTS." PEDIATRIC BLOOD & CANCER , vol.60, pp.176-177.

@article{article, author={GÜLAY SEZGİN Et Al. }, title={MEROPENEM VERSUS PIPERACILLIN-TAZOBACTAM AS EMPIRIC THERAPY FOR FEBRILE NEUTROPENIA IN PEDIATRIC ONCOLOGY PATIENTS}, journal={PEDIATRIC BLOOD & CANCER}, year=2013, pages={176-177} }